Sugammadex has been approved for use in pediatric patients by several regulatory agencies, including the FDA. However, its use may still be relatively limited in some regions due to cost considerations and clinical practice guidelines. It is essential for healthcare providers to stay updated with local regulations and guidelines regarding the use of sugammadex in children.
